WHA is hiring - join us!

The World Hepatitis Alliance are looking to recruit an Events and Partnership Officer!

It is an exciting time to be joining the World Hepatitis Alliance (WHA), our five-year strategy will support and accelerate efforts to eliminate viral hepatitis globally within ten years. Alongside the new strategy we have a new brand, a new website and new suite of exciting campaigns, programmes and events, including the World Hepatitis Summit.

The World Hepatitis Summit is a global conference which brings together diverse stakeholders to advance the fight to eliminate viral hepatitis by 2030. The third summit was held in June 2022 and was opened by the Director General of the World Health Organization, Dr Tedros Adhanom Ghebreyesus, and attracted delegates from 120 countries. Building on this success, we are now planning the next summit which will be held in Lisbon, Portugal in April 2024.

This is an exciting opportunity to help deliver this important global event. Additionally, the post holder will support WHA in the delivery of other online and in-person events and programmes.

If you want to join an ambitious and dynamic team that works at a global level to make a difference, then this role is for you.

We are looking for someone to work closely with the Senior Events and Sponsorship Coordinator and Head of Global Partnerships to ensure the World Hepatitis Summit is successfully delivered.

In return you will receive a competitive salary and annual leave allowance, as well as the chance to make a real difference to the lives of people affected by viral hepatitis.

How to apply!

To apply please send in a covering letter highlighting how you meet the person specification together with your CV.

Please send applications to admin@worldhepatitisalliance.org

The application deadline is midnight Sunday 10 September 2023.   

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close